
Ingelheim am Rhein • Europe/Berlin
Already received a doctoral degree | August 2019
University of Liverpool (Website)
Title: The Impact of Leadership on Employee Creativity and Organizational Innovation: A case study on Boehringer Ingelheim’s Middle East Turkey and Africa organization
Nature of thesis research: Doctor of Business Administration (DBA)
Affiliated Faculty
Dr. Levent Yildiz is a highly accomplished healthcare executive with over 20 years of experience in market access, pricing, business development, and regional marketing in the pharmaceutical industry. His expertise spans across multiple therapeutic areas, including speciality and primary care, and he has a track record of success in both mature and emerging markets.
Dr. Yildiz has held leadership positions at major pharmaceutical firms including Boehringer Ingelheim, GlaxoSmithKline, and Roche, where he consistently outperformed expectations in terms of revenue and market share growth. His background includes building market access operations from the bottom up, designing pricing and reimbursement strategies, launching new medicines, and establishing health economics and outcomes research (HEOR) programs.
Dr. Yildiz has a thorough understanding of healthcare systems including healthcare coverage, policies, pricing, access barriers and regulatory frameworks across all Emerging markets i.e., LATAM, Asia, Asia-Pacific and Africa. His exceptional leadership skills are complemented by postgraduate degrees in business administration and health economics. He is fluent in several languages, reflecting his international background. Dr. Yildiz's vast publishing record demonstrates his contributions to the subject of healthcare economics as well as his commitment to innovative healthcare delivery systems.
Dr. Levent joined DoctorateHub as an Affiliated Faculty member in the autumn of 2024.
No data found.
Years of Experience
30 Years
Yildiz, A. L. (2019). The Impact of Leadership on Employee Creativity and Organisational Innovation: A case study on Boehringer Ingelheim’s Middle East Turkey and Africa organization. [Doctoral Dissertation, University of Liverpool].
Budget Impact Analysis of Empagliflozin (Jardiance) in Type-2 Diabetes Patients with High Cardiovascular Risk in the South African Setting: A Retrospective Claim Database Analysis (2017, ISPOR)
Budget Impact of Alteplase in Treatment of Acute Ischemic Stroke in Turkey (2017, ISPOR)
The Clinical and Economic Burden of Idiopathic Pulmonary Fibrosis in Algeria (2018, ISPOR)
Budget Impact Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in Turkey (2018, ISPOR)
Annual Cost of Illness of Ischemic Stroke in Type 2 Diabetics in Turkey (ISPOR, 2018)
Economic burden of thromboembolic and hemorrhagic complications innon-valvular atrial fibrillation in Algeria (the ELRAGFA study) (2018, Journal of Medical Economics)
We use cookies to provide you with a great user experience.
By using DoctorateHub, you accept our use of cookies.